Molecular mechanisms of neurotransmitter release

Muscle and Nerve

Volumn 24, Issue 5, 2001, Pages 581-601

  Fon, Edward A ^a,b   Edwards, Robert H ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Exocytosis; Quantal release; Synaptic transmission; Synaptic vesicles; Transporters

Indexed keywords

NEUROTRANSMITTER;

BIOSYNTHESIS; CELL ACTIVITY; CELL FUSION; DEGRADATION; ENDOCYTOSIS; NERVE CELL; NERVE ENDING; NEUROTRANSMISSION; NEUROTRANSMITTER RELEASE; POSTSYNAPTIC POTENTIAL; PRESYNAPTIC NERVE; PRIORITY JOURNAL; REVIEW; SYNAPSE VESICLE; SYNAPTIC POTENTIAL; SYNAPTIC TRANSMISSION;

ANIMALS; HUMANS; NERVE TISSUE PROTEINS; NEUROTRANSMITTER AGENTS; SYNAPSES; SYNAPTIC VESICLES;

EID: 0035030442     PISSN: 0148639X     EISSN: None     Source Type: Journal    
DOI: 10.1002/mus.1044     Document Type: Review

References (269)

1. The exocytotic event in chromaffin cells revealed by patch amperometry
2. High calcium concentrations shift the mode of exocytosis to the kiss-and-run mechanism
3. Release of secretory products during transient vesicle fusion
4. Neurotransmitter transporters as molecular targets for addictive drugs
5. Regulation of dense core release from neuroendocrine cells revealed by imaging single exocytic events
6. 2+-activated exocytosis
7. Acute regulation of norepinephrine transport: II. PKC-modulated surface expression of human norepinephrine transporter proteins
8. Drosophila UNC-13 is essential for synaptic transmission
9. Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance
10. Munc13-1 is essential for fusion competence of glutamatergic synaptic vesicles
11. The Caenorhabditis elegans unc-31 gene affects multiple nervous system-controlled functions
12. 3H-norepinephrine by tissues
13. SV2, a brain synaptic vesicle protein homologous to bacterial transporters
14. Selective storage of acetylcholine, but not catecholamines, in neuroendocrine synaptic-like microvesicles of early endosomal origin
15. The localization of the brain-specific inorganic phosphate transporter suggests a specific presynaptic role in glutamatergic transmission
16. Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter
17. Syntaxin: A synaptic protein implicated in docking of synaptic vesicles at presynaptic active zones
18. The molecular machinery for secretion is conserved from yeast to neurons
19. A molecular description of synaptic vesicle membrane trafficking
20. Clearance of glutamate inside the synapse and beyond
21. Synaptic activation of glutamate transporters in hippocampal astrocytes
22. CAPS (mammalian UNC-31) protein localizes to membranes involved in dense-core vesicle exocytosis
23. Munc13-1 is a presynaptic phorbol ester receptor that enhances neurotransmitter release
24. Direct interaction of the rat unc-13 homologue Munc13-1 with the N terminus of syntaxin
25. Optical analysis of synaptic vesicle recycling at the frog neuromuscular junction
26. Functional impact of syntaxin on gating of N-type and Q-type calcium channels
27. Regulated phosphorylation and trafficking of antidepressant-sensitive serotonin transporter proteins
28. Glutamate transporter gene expression in amyotrophic lateral sclerosis motor cortex
29. Absence of synaptotagmin disrupts excitation-secretion coupling during synaptic transmission
30. Syntaxin and synaptobrevin function downstream of vesicle docking in Drosophila
31. Sequential steps in clathrin-mediated synaptic vesicle endocytosis
32. Mammalian homologues of Caenorhabditis elegans unc-13 gene define novel family of C2-domain proteins
33. The stiff man and stiff man plus syndromes
34. Real-time measurement of transmitter release from single synaptic vesicles
35. Synaptic vesicle biogenesis, docking and fusion: A molecular description
36. Initial docking of ER-derived vesicles requires Usolp and Yptlp but is independent of SNARE proteins
37. Membrane-bound choline-O-acetyltransferase in rat hippocampal tissue is associated with synaptic vesicles
38. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA
39. Rab3A is essential for mossy fibre long-term potentiation in the hippocampus
40. 2+ channels and snare proteins in neurotransmitter release
41. Dephosphorylated synapsin I anchors synaptic vesicles to actin cytoskeleton: An analysis by videomicroscopy
42. Milieu-induced, selective aggregation of regulated secretory proteins in the trans-Golgi network
43. 2+-triggered dimerization
44. 2+-binding loop of synaptotagmin with lipid bilayers
45. Delineation of the oligomerization, AP-2 binding, and synprint binding region of the C2B domain of synaptotagmin
46. 2+ regulates the interaction between synaptotagmin and syntaxin 1
47. Calcium-dependent interaction of the cytoplasmic region of synaptotagmin with membranes. Autonomous function of a single C2-homologous domain
48. The vesicular GABA transporter, VGAT, localizes to synaptic vesicles in sets of glycinergic as well as GABAergic neurons
49. Molecular analysis of system N suggests novel physiological roles in nitrogen metabolism and synaptic transmission
50. Multiple forms of dynamin are encoded by shibire, a Drosophila gene involved in endocytosis
51. 2+ and drives membrane fusion
52. Delay in vesicle fusion revealed by electrochemical monitoring of single secretory events in adrenal chromaffin cells
53. Glutamate immunoreactivity in rat cerebral cortex is reversibly abolished by 6-diazo-5-oxo-L-norleucine (DON), an inhibitor of phosphate-activated glutaminase
54. Acetylcholine
55. Synaptic vesicle endocytosis
56. Abnormal neurotransmission in mice lacking synaptic vesicle protein 2A (SV2A)
57. Regulated trafficking of the human dopamine transporter. Clathrin-mediated internalization and lysosomal degradation in response to phorbol esters
58. A role of amphiphysin in synaptic vesicle endocytosis suggested by its binding to dynamin in nerve terminals
59. 2+ and assembly with the core SNARE complex onto membranes
60. Identification of the major synaptojanin-binding proteins in brain
61. Transporter buffer synaptically released glutamate on a submillisecond time scale
62. The effect on synaptic physiology of synaptotagmin mutations in Drosophila
63. Neural degeneration and the transport of neurotransmitters
64. Neurotransmitter release: Variations on a theme
65. Expression cloning of a reserpine-sensitive vesicular monoamine transporter
66. Functional identification of a vesicular acetylcholine transporter and its expression from a "cholinergic" gene locus
67. A practical guide to the recognition and management of myasthenia gravis
68. Functional diversity of excitatory amino acid transporters: Ion channel and transport modes
69. An excitatory amino-acid transporter with properties of a ligand-gated chloride channel
70. A function for the AP3 coat complex in synaptic vesicle formation from endosomes
71. The synaptic vesicle protein SV2 is a novel type of transmembrane transporter
72. Cytidylyltransferase-binding protein is identical to transcytosis-associated protein (TAP/p115) and enhances the lipid activation of cytidylytransferase
73. Genetics of synaptic vesicle function: Toward the complete functional anatomy of an organelle
74. Chemical release of dopamine from striatal homogenates: Evidence for an exchange diffusion model
75. Vesicular transport regulates monoamine storage and release but is not essential for amphetamine action
76. Mental depression in hypertensive patients treated for long periods with high doses of reserpine
77. The role of Rab3A in neurotransmitter release
78. 2+ sensor for transmitter release at a central synapse
79. The small GTP-binding protein Rab3A regulates a late step in synaptic vesicle fusion
80. RAB3 and synaptotagmin: The yin and yang of synaptic membrane fusion
81. Expression of the putative vesicular acetylcholine transporter in rat brain and localization in cholinergic synaptic vesicles
82. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter
83. The evaluation of anti-parkinson drugs on reserpine-induced rigidity in rats
84. Regulation of membrane trafficking: Structural insights from a Rab/effector complex
85. Increased stress response and beta-phenylethylamine in MAOB-deficient mice
86. Endocytosis of VAMP is facilitated by a synaptic vesicle targeting signal
87. The exocyst is an affector for Sec4p, targeting secretory vesicles to sites of exocytosis
88. Glutamate as a CNS transmitter. I. Evaluation of glucose and glutamine as percursors for the synthesis of preferentially released glutamate
89. Structure and conformational changes in NSF and its mmebrane receptor complexes visualized by quick-freeze/deep-etch electron microscopy
90. AP-2 recruitment to synaptotagmin stimulated by tyrosine-based endocytic motifs
91. 2+-activated secretion
92. Resolution of regulated secretion into sequential MgATP-dependent and calcium-dependent stages mediated by distinct cytosolic proteins
93. 2+-activated secretion
94. Synaptic vesicle membrane fusion complex: Action of clostridial neurotoxins on assembly
95. The sec6/8 complex is located at neurite outgrowth and axonal synapse-assembly domains
96. Fast steps in exocytosis and endocytosis studied by capacitance measurements in endocrine cells
97. Mechanisms of alphalatrotoxin action
98. The probability of transmitter release at a mammalian central synapse
99. Review of electron microscopic evidence favouring vesicle exocytosis as the structural basis for quantal release during synaptic transmission
100. Structural changes after transmitter release at the frog neuromuscular junctionq
101. Synapsins as regulators of neurotransmitter release
102. Dynamin self-assembles into rings suggesting a mechanism for coated vesicle budding
103. A phospho-switch controls the dynamic association of synapsins with synaptic vesicles
104. Subunit composition, protein interactions, and structures of the mammalian brain sec6/8 complex and septin filaments
105. Activity-dependent changes in partial VAMP complexes during neurotransmitter release
106. A post-docking role for synaptobrevin in synaptic vesicle fusion
107. Synapsin I (protein I), a nerve terminal-specific phosphoprotein. III. Its association with synaptic vesicles studied in a highly purified synaptic vesicle preparation
108. Counting quanta: Direct measurements of transmitter release at a central synapse
109. 2+ regulators in neurotransmitter release
110. Profound neuronal plasticity in response to inactivation of the dopamine transporter
111. Defective recycling of synaptic vesicles in synaptotagmin mutants of Caenorhabditis elegans
112. Epilepsy in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase
113. Increased anxiety and altered responses to anxiolytics in mice deficient in the 65-kDa isoform of glutamic acid decarboxylase
114. The release of neural transmitter substances
115. Characterization of the cysteine-rich region of the Caenorhabditis elegans protein Unc-13 as a high affinity phorbol ester receptor. Analysis of ligand-binding interactions, lipid cofactor requirements, and inhibitor sensitivity
116. Characteristics of an amino acid transport system in rat liver for glutamine, asparagine, histidine, and closely related analogs
117. A phosphorylation site regulates sorting of the vesicular acetylcholine transporter to dense core vesicles
118. α-Latrotoxin stimulates exocytosis by the interaction with a neuronal G-protein-coupled receptor
119. Essential role of the disulfide-bonded loop of chromogranin B for sorting to secretory granules is revealed by expression of a deletion mutant in the absence of endogenous granin synthesis
120. Intricate regulation of tyrosine hydroxylase activity and gene expression
121. Facilitation of synaptic transmission by EGL-30 Gqalpha and EGL-8 PLCbeta: DAG binding to UNC-13 is required to stimulate acetylcholine release
122. Pargyline prevents MPTP-induced parkinsonism in primates
123. EAT-4, a homolog of a mammalian sodium-dependent inorganic phosphate cotransporter, is necessary for glutamatergic neurotransmission in Caenorhabditis elegans
124. Listening to neurotransmitter transporters
125. 2+-dependent and -independent activities of neural and non-neural synaptotagmins
126. Impairment of synaptic vesicle clustering and of synaptic transmission, and increased seizure propensity, in synapsin I-deficient mice
127. Aberrant RNA processing in a neurodegenerative disease: The cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis
128. Structural organization of the synaptic exocytosis core complex
129. Temperature-sensitive paralytic mutations demonstrate that synaptic exocytosis requires SNARE complex assembly and disassembly
130. Synaptic function modulated by changes in the ratio of synaptotagmin I and IV
131. Variability of neurotransmitter concentration and nonsaturation of postsynaptic AMPA receptors at synapses in hippocampal cultures and slices
132. Differential localization of vesicular acetylcholine and monoamine transporters in PC12 cells but not CHO cells
133. The role of vesicular transport proteins in synaptic transmission and neural degeneration
134. + toxicity encodes a vesicular amine transporter
135. Gene transfer of a reserpine-sensitive mechanism of resistance to N-methyl-4-phenylpyridinium
136. Preferential localization of a vesicular monoamine transporter to dense core vesicles in PC12 cells
137. Specific binding of phosphatidylinositol 4,5-bisphosphate to calcium-dependent activator protein for secretion (CAPS), a potential phosphoinositide effector protein for regulated exocytosis
138. t-SNARE activation through transient interaction with a rab-like guanosine triphosphatase
139. Energy on demand
140. Synaptic calcium transients in single spines indicate that NMDA receptors are not saturated
141. Long-term potentiation - A decade of progress?
142. The structural era of endocytosis
143. The molecular machinery for fast and slow neurosecretion
144. A phorbol ester/diacylglycerol-binding protein encoded by the unc-13 gene of Caenorhabditis elegans
145. Neurotransmitter transporters in the central nervous system
146. 2+ channels
147. Identification and characterization of the vesicular GABA transporter
148. A presynaptic inositol-5-phosphatase
149. Synaptojanin forms two separate complexes in the nerve terminal. Interactions with endophilin and amphiphysin
150. Anticholinesterases: Medical applications of neurochemical principles
151. Goalpha and diacylglycerol kinase negatively regulate the Gq-alpha pathway in C. elegans
152. Overexpression of synaptotagmin modulates short-term synaptic plasticity at developing neuromuscular junctions
153. Differential sorting of nerve growth factor and brain-derived neurotrophic factor in hippocampal neurons
154. Synaptic vesicles retain their identity through the endocytic cycle
155. The role of monoamine oxidase and catechol-O-methyltransferase in dopaminergic neurotransmission
156. 2+ microdomains: New tools for understanding their roles in neurotransmitter release
157. - neurotransmitter transporters
158. Ultrastructural localization of the vesicular monoamine transporter-2 in midbrain dopaminergic neurons: Potential sites for somatodendritic storage and release of dopamine
159. Vesicular monoamine transporter-2: Immunogold localization in striatal axons and terminals
160. The vesicular monoamine transporter-2 is present in small synaptic vesicles and preferentially localizes to large dense core vesicles in rat solitary tract nuclei
161. Caenorhabditis elegans rab-3 mutant synapses exhibit impaired function and are partially depleted of vesicles
162. Identification and characterization of the high-affinity choline transporter
163. Vesicles on strings: Morphological evidence for processive transport within the Golgi stack
164. Structure of alphalatrotoxin oligomers reveals that divalent cation-dependent tetramers form membrane pores
165. Metabolic compartmentation of glutamate and glutamine: Morphological evidence obtained by quantitative immunocytochemistry in rat cerebellum
166. The identification of a novel synaptosomal-associated protein, SNAP-25, differentially expressed by neuronal subpopulations
167. Study of subcellular localization of membrane-bound choline acetyltransferase in Drosophila central nervous system and its association with membranes
168. Acetylcholinesterase clustering at the neuromuscular junction involves perlecan and dystroglycan
169. The chromaffin granule and synaptic vesicle amine transporters differ in substrate recognition and sensitivity to inhibitors
170. Control of the terminal step of intracellular membrane fusion by protein phosphatase 1
171. 2+ calmodulin signals the completion of docking and triggers a late step of vacuole fusion
172. Distinct pools of synaptic vesicles in neurotransmitter release
173. Reversible alteration in the neuromuscular junctions of Drosophila melanogaster bearing a temperature-sensitive mutation, shibire
174. Synaptic vesicle transporter expression regulates vesicle phenotype and quantal size
175. Developmental expression of excitatory amino acid transporter 5: A photoreceptor and bipolar cell glutamate transporter in rat retina
176. Phosphorylation and sequestration of serotonin transporters differentially modulated by psychostimulants
177. Phosphorylation and regulation of antidepressant-sensitive serotonin transporters
178. Cysteine string protein is required for calcium secretion coupling of evoked neurotransmission in drosophila but not for vesicle recycling
179. Amino acid transport system A resembles system N in sequence but differs in mechanism
180. Vesicular neurotransmitter transport and the presynaptic regulation of quantal size
181. UNC-13 is required for synaptic vesicle fusion in C. elegans
182. 2+-binding domain
183. Molecular cloning of a putative vesicular transporter for acetylcholine
184. The endocytic machinery in nerve terminals surrounds sites of exocytosis
185. Essential functions of synapsins I and II in synaptic vesicle regulation
186. Nonuniform probability of glutamate release at a hippocampal synapse
187. Definition of the readily releasable pool of vesicles at hippocampal synapses
188. SNARE motif and neurotoxins
189. Mechanisms of intracellular protein transport
190. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate
191. Alteration of striatal glutamate release after glutamine synthetase inhibition
192. Transplantation of quail collagen-tailed acetylcholinesterase molecules onto the frog neuromuscular synapse
193. The kinetics of synaptic vesicle recycling measured at single presynaptic boutons
194. Vesicle pool mobilization during action potential firing at hippocampal synapses
195. Potentiation of evoked vesicle turnover at individually resolved synaptic boutons
196. Regulation of the UNC-18-Caenorhabditis elegans syntaxin complex by UNC-13
197. 2+ channels in electric ray nerve endings
198. Clostridial neurotoxins as tools to investigate the molecular events of neurotransmitter release
199. Isoform-specific, calcium-regulated interaction of the synaptic vesicle proteins SV2 and synaptotagmin
200. Dynamin and its partners: A progress report
201. Endophilin I mediates synaptic vesicle formation by transfer of arachidonate to lysophosphatidic acid
202. Excitatory amino acid transporters: A family in flux
203. Amphetamine: Effects on catecholamine systems and behavior
204. Impairment of dynamin's GAP domain stimulates receptor-mediated endocytosis
205. 2+ induce a conformational change?
206. 2+-dependent electrostatic switch
207. Neuroendocrine synaptic vesicles are formed in vitro by both clathrin-dependent and clathrin-independent pathways
208. Monoamine oxidase: From genes to behavior
209. DATATOP: A decade of neuroprotective inquiry. Parkinson study group. Deprenyl and tocopherol antioxidative therapy of parkinsonism
210. Synaptic vesicle endocytosis impaired by disruption of dynamin-SH3 domain interactions
211. Two isoforms of glutamate decarboxylase: Why?
212. Autoimmunity to glutamic acid decarboxylase (GAD) in stiff-man syndrome and insulin-dependent diabetes mellitus
213. Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome
214. A protein assembly-disassembly pathway in vitro that may correspond to sequential steps of synaptic vesicle docking, activation, and fusion
215. Neurotransmission: Harnessing fusion machinery at the synapse
216. SNAP receptors implicated in vesicle targeting and fusion
217. Channels in transporters
218. Multiple ionic conductances of the human dopamine transporter: The actions of dopamine and psychostimulants
219. Expression of a putative vesicular acetylcholine transporter facilitates quantal transmitter packaging
220. Kinetic analysis of the phosphorylation-dependent interactions of synapsin I with rat brain synaptic vesicles
221. Calmodulin confers calcium sensitivity on secretory exocytosis
222. The synaptic vesicle cycle: A cascade of protein-protein interactions
223. Synaptotagmins: C2-domain proteins that regulate membrane traffic
224. 2+-dependent properties of the first and second C2-domains of synaptotagmin I
225. Neurexins are functional alpha-latrotoxin receptors
226. P/Q-type calcium channels mediate the activity-dependent feedback of syntaxin-1A
227. 2+ phospholipid-binding fold
228. Crystal structure of a SNARE complex involved in synaptic exocytosis at 2.4 A resolution
229. VMAT2 knockout mice: Heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity
230. Tubular membrane invaginations coated by dynamin rings are induced by GTP-gamma S in nerve terminals
231. Identification of a system N-like Na(+)-dependent glutamine transport activity in rat brain neurons
232. A leucine-based motif mediates the endocytosis of vesicular monoamine and acetylcholine transporters
233. Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-I
234. Differential regulation of exocytosis by calcium and CAPS in semi-intact synaptosomes
235. The exocyst is a multiprotein complex required for exocytosis in Saccharomyces cerevisiae
236. 14C]glutamine
237. The role of the synthetic enzyme GAD65 in the control of neuronal gamma-aminobutyric acid release
238. Bassoon, a novel zinc-finger CAG/glutamine-repeat protein selectively localized at the active zone of presynaptic nerve terminals
239. VAMP-1: A synaptic vesicle-associated integral membrane protein
240. 2-domain?
241. Rab GDP dissociation inhibitor as a general regulator for the membrane association of rab proteins
242. Attenuated influx of calcium ions at nerve endings of csp and shibire mutant Drosophila
243. Defining the functions of trans-SNARE pairs
244. Dynamin-like protein encoded by the Drosophila shibire gene associated with vesicular traffic
245. The cytoplasmic tail of the vesicular acetytchotine transporter contains a synaptic vesicle targeting signal
246. Cloning and functional identification of a neuronal glutamine transporter
247. The highly integrated dialogue between neurons and astrocytes in brain function
248. Ion fluxes associated with excitatory amino acid transport
249. 2+-regulated secretion in permeable neuroendocrine cells
250. Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine
251. Dynamin GTPase, a force-generating molecular switch
252. SNAREpins: Minimal machinery for membrane fusion
253. Visualization of the vesicular acetylcholine transporter in cholinergic nerve terminals and its targeting to a specific population of small synaptic vesicles
254. Chromaffin granule-associated phosphatidylinositol 4-kinase activity is required for stimulated secretion
255. An essential role for a small synaptic vesicle-associated phosphatidylinositol 4-kinase in neurotransmitter release
256. Time course of release of catecholamines from individual vesicles during exocytosis at adrenal medullary cells
257. Membrane composition of adrenergic large and small dense cored vesicles and of synaptic vesicles: Consequences for their biogenesis
258. Choline acetyltransferase: Celebrating its fiftieth year
259. Genetic dissection of synaptic transmission in Drosophila
260. Multiple kinetic components of exocytosis distinguished by neurotoxin sensitivity
261. Passive transfer of Lambert-Eaton myasthenic syndrome induces dihydropyridine sensitivity of 1Ca in mouse motor nerve terminals
262. SNARE interactions are not selective. Implications for membrane fusion specificity
263. Flux coupling in a neuronal glutamate transporter
264. Synaptotagmin I is a high affinity receptor for clathrin AP-2: Implications for membrane recycling
265. 2+ channels by SNAP-25, syntaxin and synaptotagmin
266. Targeted disruption of the tyrosine hydroxylase gene reveals that catecholamines are required for mouse fetal development
267. Acute regulation of tyrosine hydroxylase by nerve activity and by neurotransmitters via phosphorylation